IVF

Fertility Centers of New England Acquires Fertility Solutions to Expand First Fertility Network

Retrieved on: 
火曜日, 2月 6, 2024
Biotechnology, Health, Family, Finance, Consumer, Banking, Professional Services, Parenting, Managed Care, General Health, LGBTQ+, Baby, Maternity, Health Technology, Women, Partnership, Patient, Fertility, Laboratory, Physician, Acquisition, IVF

First Fertility , one of the largest fertility networks in the United States announced today that Fertility Centers of New England , a First Fertility Center of Excellence, has acquired Fertility Solutions, a fertility center based in Massachusetts with offices also in Rhode Island.

Key Points: 
  • First Fertility , one of the largest fertility networks in the United States announced today that Fertility Centers of New England , a First Fertility Center of Excellence, has acquired Fertility Solutions, a fertility center based in Massachusetts with offices also in Rhode Island.
  • This partnership adds six new locations and four highly regarded, experienced, and compassionate physicians to Fertility Centers of New England, furthering the company’s vision to make fertility treatment more accessible in every community that we serve.
  • “My colleagues and I are excited to join FCNE, “said Dr. Ania Kowalik, Partner at Fertility Solutions.
  • “We look forward to continuing our tradition of providing outstanding care to those needing our services as part of Fertility Centers of New England,” she continued.

Alife Health Partners with Ovation Fertility on Cutting-Edge AI Technology for Embryo Image Capture and Cataloguing

Retrieved on: 
火曜日, 2月 6, 2024
Partnership, Embryo, SAN, Family, Ovation, AI, Machine learning, Laboratory, CDS, Doctor of Philosophy, Software, IVF, Medical device

SAN FRANCISCO, Feb. 6, 2024 /PRNewswire/ -- Alife Health ("Alife"), a fertility technology company building AI tools to advance in-vitro fertilization (IVF), announced today that it has partnered with Ovation® Fertility ("Ovation"), a US Fertility company and national network of laboratories to pilot the world's first embryo image cataloging software. This software could enable future AI-powered embryo selection. Alife's Embryo Assist™ software enables embryologists to seamlessly create digital records of every embryo, with the added benefit of leveraging Alife's Clinical Decision Support (CDS) algorithm to determine the best embryo for transfer.

Key Points: 
  • SAN FRANCISCO, Feb. 6, 2024 /PRNewswire/ -- Alife Health ("Alife"), a fertility technology company building AI tools to advance in-vitro fertilization (IVF), announced today that it has partnered with Ovation® Fertility ("Ovation"), a US Fertility company and national network of laboratories to pilot the world's first embryo image cataloging software.
  • Alife's Embryo Assist™ software enables embryologists to seamlessly create digital records of every embryo, with the added benefit of leveraging Alife's Clinical Decision Support (CDS) algorithm to determine the best embryo for transfer.
  • "The Alife Embryo Assist software provides our laboratories with a structured digital approach to a rather manual and cumbersome process.
  • Alife expects this tool to elevate laboratory quality-control measures by providing an activity and audit trail for every embryo, viewable in real-time.

Bow Valley College once again named one of Alberta’s Top 75 Employers

Retrieved on: 
火曜日, 1月 30, 2024
Growth, Knowledge, City, Wellness, Christmas, Inclusion, Mental, Bow Valley College, Professional, Education, Culture, Camping, Mental health, Town hall, IVF, Nursing

Calgary, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Bow Valley College is honoured to maintain its standing as one of Alberta’s Top 75 Employers .

Key Points: 
  • Calgary, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Bow Valley College is honoured to maintain its standing as one of Alberta’s Top 75 Employers .
  • Eligible Bow Valley College employees are also enjoying increased flexibility with a special taxable account funded by the college through the Wellness Spending Account.
  • Its main campus is conveniently located in downtown Calgary, with the newly named City Hall – Bow Valley College CTrain station at its doorstep.
  • Bow Valley College has regional campuses located in Okotoks, Airdrie, Cochrane, and Banff.

Vytelle announces a strategic collaboration with Blocktrust Network to promote the value of feeder cattle on the basis of growth and efficiency bringing more transparency to this critical market segment in the beef supply chain

Retrieved on: 
火曜日, 1月 30, 2024
Genetics, Cattle, Database, Blockchain, API, IVF

This collaboration marks the first of its kind aimed to leverage their respective strengths targeting the feeder cattle market.

Key Points: 
  • This collaboration marks the first of its kind aimed to leverage their respective strengths targeting the feeder cattle market.
  • Leveraging the power of the Vytelle’s industry leadership in characterizing feed efficient genetics, Vytelle will develop tools to characterize differences in feed efficiency among groups of feeder cattle via the Blocktrust Network’s permissioned blockchain.
  • “We are thrilled to embark on this groundbreaking collaboration with Blocktrust,” said Kerryann Kocher, CEO of Vytelle.
  • ‘Blockchain technology has proven to be a transformative force across various industries and Blocktrust Network is thrilled to bring a new level of transparency to the beef supply chain’ said Gregg Barfield, CEO of Blocktrust Network.

IVI RMA Completes Acquisition of North American Operations of Eugin Group, Including Boston IVF and TRIO

Retrieved on: 
水曜日, 1月 31, 2024
Health, General Health, Trio, Parent, IVI, Boston Medical Center, Patient, Dream, Fertility, TRIO, Harvard Medical School, Tufts Medical Center, Acquisition, Reproductive medicine, IVF

IVI RMA, one of the largest reproductive medicine groups in the world, today announced that it has completed the acquisition of North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO.

Key Points: 
  • IVI RMA, one of the largest reproductive medicine groups in the world, today announced that it has completed the acquisition of North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO.
  • In addition, Boston IVF brings multiple academic affiliations, including Harvard Medical School, Dartmouth Hitchcock Medical School, Boston University Medical Center, and Tufts Medical Center, among others.
  • “We are excited to officially welcome Boston IVF, its partner clinics and TRIO to the IVI RMA network,” added Lynn Mason, CEO of IVI RMA America.
  • “Together with IVI RMA, we will continue to pave the way for breakthroughs in fertility care.”

Gattaca Genomics Unveils State-of-the-Art Genetic Testing Services to Transform Family Planning

Retrieved on: 
木曜日, 1月 18, 2024
Entrepreneurship, Family, Whole genome sequencing, Patient, Regenerative medicine, Heart, IVF, Knowledge, Reproductive medicine, Genetics, WGS, Genetic testing, Risk, Quality of life, Genomics, Genetic counseling, Genome, DSM-IV codes, PGT, Chromosome, Management

Fort Lauderdale, FL, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics, a pioneering next generation company innovating solutions for reproductive health, is set to revolutionize family planning with its advanced genetic testing services.

Key Points: 
  • Fort Lauderdale, FL, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics, a pioneering next generation company innovating solutions for reproductive health, is set to revolutionize family planning with its advanced genetic testing services.
  • Specializing in Preimplantation Genetic Testing (PGT), Gattaca Genomics employs state-of-the-art techniques to enhance pregnancy success rates, identify chromosomal abnormalities, and reduce the risk of genetic disorders.
  • Whole Genome Sequencing (WGS): Gattaca Genomics introduces a breakthrough in genetic testing with Whole Genome Sequencing, offering a comprehensive analysis of an individual's entire genome.
  • Gattaca Genomics invites prospective parents, healthcare providers, and clinicians to explore the possibilities that genetic testing can offer.

Accolade Welcomes Kindbody to Trusted Partner Ecosystem

Retrieved on: 
火曜日, 1月 23, 2024
Fertility, Infertility, Health, IVF, Partnership, Female, Male, Menopause, Workplace, Genetic testing, Trusted Partner, Education, ACCD, Birth control

SEATTLE, Jan. 23, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) today announced that Kindbody, a technology-driven fertility clinic network and family-building benefits provider for employers, will join the company's Trusted Partner Ecosystem to offer Accolade customers comprehensive, clinically guided support and care throughout a member's fertility and family-building journey, all backed by a new cost savings performance guarantee.

Key Points: 
  • Kindbody addresses these issues by providing affordable fertility care and delivering a seamless, integrated experience with best-in-class outcomes.
  • Kindbody delivers this model through a combination of owned and operated signature clinics and hundreds of partner clinics nationwide.
  • Joint customers of Accolade and Kindbody will benefit from integrations designed to promote awareness of Kindbody's services, at no incremental cost to customers.
  • Launched in 2019, Accolade's Trusted Partner Ecosystem is the first in the industry to bring together multiple benefits solutions across valued categories, making them available to employers through a single front door.

Illume Fertility Partners with TMRW Life Sciences to Provide Cutting Edge Technology for the Safe Management and Storage of Frozen Eggs and Embryos for Patients

Retrieved on: 
火曜日, 1月 23, 2024
Patient, Fertility, Partner, IVF, Failure, Embryology, Risk, TMRW, Safety, Laboratory, FDA, Parent

NORWALK, Conn., Jan. 23, 2024 /PRNewswire-PRWeb/ -- Illume Fertility, a leading modern fertility practice whose exceptional quality of care helps hopeful parents grow their families, and TMRW Life Sciences, a fertility technology company, have partnered to provide Illume's patients with the world's first and only FDA-approved, automated platform for accurate management and storage of frozen eggs and embryos.

Key Points: 
  • "Tracking our patients' precious eggs and embryos is now completely digitized and seamless."
  • Illume Fertility is the only fertility center in Connecticut that has a TMRW cryo robot, and was one of the first fertility clinics in the United States to incorporate TMRW Life Sciences' automated platform into their lab.
  • The storage of eggs and embryos has always been a manual process in IVF laboratories, but with TMRW's automated platform, potential points of failure have been reduced by 93%.
  • Illume Fertility's clinicians have now modernized their specimen management and storage practices, utilizing TMRW's digital tools onsite in addition to transferring patient specimens offsite to and from TMRW Cryobanks.

CCRM FERTILITY ANNOUNCES CHELSEY LEISINGER AS NEW VP OF NETWORK LAB COMPLIANCE

Retrieved on: 
月曜日, 1月 22, 2024
Patient, Fertility, Research, Iowa State University, IVF, Science, Embryology, University School, Bachelor of Science, Laboratory, Certification, Doctor of Philosophy, Veterinary medicine, University college, Medical device

LONE TREE, Colo., Jan. 22, 2024 /PRNewswire/ -- CCRM Fertility, a leading pioneer in the fertility treatment, research, and science industry, announced today the appointment of Chelsey Leisinger, MS, PhD, HCLD/CC as VP of Network Lab Compliance.

Key Points: 
  • Dr. Leisinger joins CCRM's leading team of fertility specialists, focusing on laboratory compliance
    LONE TREE, Colo., Jan. 22, 2024 /PRNewswire/ -- CCRM Fertility, a leading pioneer in the fertility treatment, research, and science industry, announced today the appointment of Chelsey Leisinger, MS, PhD, HCLD/CC as VP of Network Lab Compliance.
  • As the newly appointed Vice President of Network Lab Compliance for CCRM, Dr. Leisinger, a renowned fertility specialist, will play a pivotal role in supervising select laboratory locations.
  • Her primary focus will be on ensuring laboratory compliance and risk mitigation, thereby elevating the fertility experience for both CCRM laboratory technologists and patients.
  • "I am thrilled to join the CCRM Fertility expert team to help further the mission of providing top-notch fertility care," said Dr. Leisinger.

Florida Reproductive Specialists by IVF FLORIDA Introduces World-Class Fertility Care to North Florida

Retrieved on: 
水曜日, 1月 17, 2024
Patient, Fertility, Gynaecology, IVF, Partnership, Cancer, Fertilisation, Suite, Fertility preservation, Birth control

Florida Reproductive Specialists is dedicated to delivering state-of-the-art technology, inclusive fertility care, and compassionate medical guidance.

Key Points: 
  • Florida Reproductive Specialists is dedicated to delivering state-of-the-art technology, inclusive fertility care, and compassionate medical guidance.
  • Florida Reproductive Specialists is a partner with IVF FLORIDA Reproductive Associates , a reputable provider of fertility treatments in South Florida since 1986.
  • With multiple locations throughout Florida, both Florida Reproductive Specialists and IVF FLORIDA Reproductive Associates deliver comprehensive and empathetic care to individuals and couples pursuing family-building solutions.
  • Florida Reproductive Specialists and IVF FLORIDA are proud partner practices of US Fertility , the largest physician-owned and physician-led partnership of top-tier fertility practices nationally.